Capital Group Private Client Services, Inc. Moderna, Inc. Transaction History

Capital Group Private Client Services, Inc.

$9.94 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $117,099 - $192,767	-1,157 Reduced 3.05%	36,726 $4.36 Million
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $642,323 - $868,570	7,524 Added 24.78%	37,883 $4.04 Million
Q4 2023 Feb 13, 2024	SELL	$69.51 - $104.43 $215,202 - $323,315	-3,096 Reduced 9.25%	30,359 $3.02 Million
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $32,682 - $42,920	-339 Reduced 1.0%	33,455 $3.46 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $4,621 - $6,260	39 Added 0.12%	33,794 $4.11 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $4.58 Million - $6.65 Million	33,755 New	33,755 $5.18 Million

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Private Client Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Private Client Services, Inc. with notifications on news.

Account